Transcriptional signature primes human oral mucosa for rapid wound healing.
Level 5 - mechanism / opinion, no new human data
Mechanistic translational study using human tissue profiling and preclinical models without clinical outcome endpoints.
PubMed 30045979 · doi:10.1126/scitranslmed.aap8798
What was done
Researchers conducted a comparative molecular profiling study of human oral and cutaneous wound healing using paired, sequential biopsies obtained across the repair timeline. They evaluated differences in baseline and injury-induced transcriptional networks between oral mucosa and skin, identified key transcription factors (SOX2 and PITX1) that distinguish oral keratinocytes, and assessed whether these regulators could reprogram skin keratinocytes to enhance migration and accelerate wound resolution in vivo.
What was found
The abstract provides no numerical data, effect estimates, or statistical values. Qualitatively, oral mucosa showed basal expression of wound-activated transcriptional networks related to epithelial differentiation and inflammation control. SOX2 and PITX1 were identified as differentially expressed master regulators in oral keratinocytes, and their expression was sufficient to reprogram cutaneous keratinocytes, increasing cell migration and improving in vivo wound healing.
Why it matters
This work identifies specific transcriptional regulators underlying the superior healing capacity of human oral mucosa, pointing to SOX2 and PITX1 as potential therapeutic targets to accelerate healing in chronic skin wounds.
Limits
No sample sizes, quantitative measurements, or patient clinical characteristics are reported in the abstract. In vivo validation details are unspecified, and direct therapeutic efficacy in human clinical wounds remains unproven.
Cited by
- supports Wounds inside the human mouth heal rapidly and often with minimal or no scarring.